title: Extended-release Methylphenidate Treatment and Outcomes in Comorbid Social Anxiety Disorder and Attention-deficit/Hyperactivity Disorder: 2 Case Reports.
abstract: Social anxiety disorder is frequently comorbid with attention-deficit/hyperactivity disorder (ADHD). However, treatment recommendations are not clear in the presence of such comorbidity. A few studies in the literature have reported improvement in symptoms of both disorders with treatment specific for ADHD (ie, stimulants and atomoxetine). In this report, we present cases of 2 adults with social anxiety disorder and ADHD who were treated with methylphenidate monotherapy. Both cases responded well in terms of not only their ADHD symptoms but also the social anxiety disorder symptoms. Methylphenidate was well tolerated with no significant side effects. More studies are needed to better establish the potential of ADHD medications to be effective for comorbid social anxiety disorder symptoms.
authors.affiliation: KOYUNCU: Academy Social Phobia Center, Istanbul, Turkey ÇELEBI: Department of Child and Adolescent Psychiatry, Zonguldak Women and Children Hospital, Zonguldak, Turkey ERTEKIN: Department of Psychiatry, Istanbul Medical School, Istanbul University, Istanbul, Turkey KAHN: Columbia University College of Physicians and Surgeons, New York, NY.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Koyuncu
authors.forename: Fahri
authors.initials: F
authors.lastname: Çelebi
authors.forename: Erhan
authors.initials: E
authors.lastname: Ertekin
authors.forename: David A
authors.initials: DA
authors.lastname: Kahn
mesh_terms: D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000453:epidemiology; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage / Q000494:pharmacology*; D010698:Phobic Disorders / Q000188:drug therapy* / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000697:Central Nervous System Stimulants; D003692:Delayed-Action Preparations; D008774:Methylphenidate